Thomas Chilcott, III

Mr. Chilcott joined Theralink as Chief Financial Officer in September 2020. With over 30 years of financial and operational experience in publicly traded and privately-owned companies, Mr. Chilcott has provided guidance on capital formation, M&A, restructuring, and creating shareholder value throughout his career.

From 2017 to 2019, Mr. Chilcott was the Chief Financial Officer, Secretary, and Treasurer of Ampio Pharmaceuticals, Inc. (NYSE: AMPE), a biotechnology company primarily focused on the development of therapies to treat prevalent inflammatory conditions. During his tenure at Ampio, he was instrumental in raising capital and leading the accounting and finance department including all SEC filings. Additionally, Mr. Chilcott was the President of Chilcott Consulting Group where for over 10 years he assisted many public and private biotechnology, healthcare and technology companies.

Mr. Chilcott holds a B.S. in Accountancy from Villanova University and is a Certified Public Accountant (CPA).